PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Sep-2025 Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business Businesswire
15-Sep-2025 NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio Businesswire
15-Sep-2025 REDCap Cloud Launches Next-Generation Clinical Trial Data and Analytics Platform to Power AI-Driven Research Businesswire
15-Sep-2025 GLASGOW FIRMS HELP ALZHEIMER RESEARCHERS TAKE A LEAP FORWARD WITH NEW SCANNER TECHNOLOGY Wideblue
15-Sep-2025 Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates Businesswire
15-Sep-2025 BODYWELLE Hosts Event Featuring Commissioner Kristen Rosen Gonzalez on Local Growth Initiatives ACCESS Newswire
15-Sep-2025 Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab Businesswire
15-Sep-2025 CatalYm Announces Leadership Changes to Accelerate Visugromab Late-stage Clinical Development Businesswire
15-Sep-2025 Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares Businesswire
15-Sep-2025 Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury Tiziana Life Sciences
15-Sep-2025 EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke Novo Nordisk
15-Sep-2025 Frank Montes De Oca and John Wagner Join the Assistance Fund's Board of Directors ACCESS Newswire
15-Sep-2025 PAO Group Inc Announces New CEO James Schramm ACCESS Newswire
15-Sep-2025 Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berlin 2025 ACCESS Newswire
15-Sep-2025 SOM Biotech receives positive EMA COMP opinion on European Orphan Drug Designation for SOM3355 for treatment of Huntington’s Disease Andrew Lloyd Associates
15-Sep-2025 enVVeno Medical Updates Regulatory Status of VenoValve(R) ACCESS Newswire
15-Sep-2025 Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study ACCESS Newswire
15-Sep-2025 Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event Businesswire
15-Sep-2025 Curatis: Double-Digit Growth in Core Business and Development Milestone Achieved for C-PTBE-01 Businesswire
15-Sep-2025 International Health Insurers to Invest USD 65 Billion in Core IT by 2027 ACCESS Newswire